|
Absci Corporation
|
-1.20 USD
|
50.833%
|
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
62.179%
|
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
83.239%
|
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
95.992%
|
|
Apollomics, Inc.
|
-2.32 USD
|
74.569%
|
|
180 Life Sciences Corp.
|
-52.60 USD
|
98.878%
|
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-145.833%
|
|
Bicycle Therapeutics plc
|
-5.08 USD
|
88.386%
|
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
69.11%
|
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
90.407%
|
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
70.792%
|
|
Chimerix, Inc.
|
-0.93 USD
|
36.559%
|
|
CRISPR Therapeutics AG
|
-1.94 USD
|
69.588%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
143.382%
|
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
67.582%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
93.034%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
93.034%
|
|
Gritstone bio, Inc.
|
-1.20 USD
|
50.833%
|
|
Allakos Inc.
|
-2.14 USD
|
72.43%
|
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
73.423%
|
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
73.059%
|
|
Cytokinetics, Incorporated
|
-5.45 USD
|
89.174%
|
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
86.918%
|
|
Innoviva, Inc.
|
2.92 USD
|
120.205%
|
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
74.348%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-84.375%
|
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
80.656%
|
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-15426.316%
|
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
53.543%
|
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
72.3%
|
|
ImmuCell Corporation
|
-0.75 USD
|
21.333%
|
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
69.898%
|
|
Incyte Corporation
|
2.67 USD
|
122.097%
|
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
90.312%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
41.584%
|
|
Mustang Bio, Inc.
|
-6.00 USD
|
90.167%
|
|
MiMedx Group, Inc.
|
0.48 USD
|
222.917%
|
|
MEI Pharma, Inc.
|
2.67 USD
|
122.097%
|
|
MacroGenics, Inc.
|
-0.15 USD
|
-293.333%
|
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
-1.724%
|
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-1219.911%
|
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
69.43%
|
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
77.567%
|
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
34.444%
|
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
87.202%
|
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
76.016%
|
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
28.916%
|
|
NextCure, Inc.
|
-2.25 USD
|
73.778%
|
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
60.135%
|
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-28.261%
|
|
Onconetix, Inc.
|
-2.19 USD
|
73.059%
|
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
95.607%
|
|
Opthea Limited
|
-0.35 USD
|
-68.571%
|
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
20.27%
|
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
92.484%
|
|
PDS Biotechnology Corporation
|
-1.39 USD
|
57.554%
|
|
Precigen, Inc.
|
-0.39 USD
|
-51.282%
|
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
97.294%
|
|
Prime Medicine, Inc.
|
-2.18 USD
|
72.936%
|
|
PureTech Health plc
|
-2.38 USD
|
75.21%
|
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
79.795%
|
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
101.592%
|
|
Replimune Group, Inc.
|
-3.24 USD
|
81.79%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-11.321%
|
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
59.028%
|
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
99.431%
|
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
84.715%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
52.8%
|
|
Sesen Bio, Inc.
|
-1.99 USD
|
70.352%
|
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
60.135%
|
|
Solid Biosciences Inc.
|
-4.83 USD
|
87.785%
|
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
80.201%
|
|
SciSparc Ltd.
|
-14.43 USD
|
95.911%
|
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
66.854%
|
|
TG Therapeutics, Inc.
|
0.09 USD
|
760.694%
|
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
99.731%
|
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
92.038%
|
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
60.667%
|
|
UroGen Pharma Ltd.
|
-3.55 USD
|
83.38%
|
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
60.135%
|
|
XOMA Corporation
|
-4.04 USD
|
85.396%
|
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
86.801%
|
|
AbCellera Biologics Inc.
|
-0.51 USD
|
-15.686%
|
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
75.314%
|
|
Cassava Sciences, Inc.
|
-2.32 USD
|
74.569%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
94.277%
|
|
Precision BioSciences, Inc.
|
-15.96 USD
|
96.303%
|
|
Dyadic International, Inc.
|
-0.24 USD
|
-145.833%
|
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
57.246%
|
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-1516.438%
|
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
78.7%
|
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
64.881%
|
|
IGM Biosciences, Inc.
|
-4.71 USD
|
87.473%
|
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-3.509%
|
|
Acelyrin, Inc.
|
-5.43 USD
|
89.134%
|
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
76.68%
|
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
119.536%
|
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
83.473%
|
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
47.321%
|
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
89.845%
|
|
Senti Biosciences, Inc.
|
-16.01 USD
|
96.315%
|
|
Mesoblast Limited
|
-0.89 USD
|
33.708%
|
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
76.587%
|
|
ChromaDex Corporation
|
-0.07 USD
|
-795.296%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-103.448%
|
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-110.714%
|
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
98.532%
|
|
Seer, Inc.
|
-1.35 USD
|
56.296%
|
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-31.111%
|
|
Novavax, Inc.
|
-5.41 USD
|
89.094%
|
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
95.451%
|
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
64.024%
|
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
78.7%
|
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
36.559%
|
|
Celcuity Inc.
|
-2.69 USD
|
78.067%
|
|
ContextLogic Inc.
|
-13.36 USD
|
95.584%
|
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
84.987%
|
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
93.163%
|
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
108.489%
|
|
Amarin Corporation plc
|
-0.15 USD
|
-293.333%
|
|
AnaptysBio, Inc.
|
-6.08 USD
|
90.296%
|
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
99.058%
|
|
Aptorum Group Limited
|
-0.62 USD
|
4.839%
|
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
98.611%
|
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
69.11%
|
|
Ardelyx, Inc.
|
-0.30 USD
|
-96.667%
|
|
Celularity Inc.
|
-11.02 USD
|
94.646%
|
|
Omeros Corporation
|
-1.88 USD
|
68.617%
|
|
Humacyte, Inc.
|
-1.07 USD
|
44.86%
|
|
Immunocore Holdings plc
|
-1.13 USD
|
47.788%
|
|
IO Biotech, Inc.
|
-1.98 USD
|
70.202%
|
|
GT Biopharma, Inc.
|
-5.64 USD
|
89.539%
|
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
64.242%
|
|
Summit Therapeutics Inc.
|
-0.99 USD
|
40.404%
|
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
97.315%
|
|
Pulmatrix, Inc.
|
-3.87 USD
|
84.755%
|
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
89.114%
|
|
Evogene Ltd.
|
-5.23 USD
|
88.719%
|
|
CorMedix Inc.
|
-0.91 USD
|
35.165%
|
|
BioLineRx Ltd.
|
-0.94 USD
|
37.234%
|
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
61.184%
|
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
77.82%
|
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
92.951%
|
|
scPharmaceuticals Inc.
|
-1.42 USD
|
58.451%
|
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
62.893%
|
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
157.843%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-84.375%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
52.8%
|
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
79.585%
|
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
54.615%
|
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
77.132%
|
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
75.21%
|
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
97.662%
|
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
87.5%
|
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
58.451%
|
|
Daré Bioscience, Inc.
|
-4.15 USD
|
85.783%
|
|
bluebird bio, Inc.
|
-1.93 USD
|
69.43%
|
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
166.292%
|
|
DBV Technologies S.A.
|
-0.76 USD
|
22.368%
|
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
79.725%
|
|
Galecto, Inc.
|
-36.08 USD
|
98.365%
|
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
51.639%
|
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
52.419%
|
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
88.477%
|
|
GlycoMimetics, Inc.
|
-0.58 USD
|
-1.724%
|
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
84.392%
|
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-353.846%
|
|
Clene Inc.
|
-9.43 USD
|
93.743%
|
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
62.658%
|
|
Aptose Biosciences Inc.
|
-7.58 USD
|
92.216%
|
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
99.946%
|
|
Soligenix, Inc.
|
-12.66 USD
|
95.34%
|
|
Century Therapeutics, Inc.
|
-2.30 USD
|
74.348%
|
|
Kura Oncology, Inc.
|
-2.08 USD
|
71.635%
|
|
Surrozen, Inc.
|
-21.33 USD
|
97.234%
|
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
56.618%
|
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-2143.346%
|
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-7562.338%
|
|
Autolus Therapeutics plc
|
-1.20 USD
|
50.833%
|
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
70.352%
|
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
85.539%
|
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
57.246%
|
|
GRI Bio, Inc.
|
-28.25 USD
|
97.912%
|
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
78.229%
|
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
55.303%
|
|
INmune Bio, Inc.
|
-1.67 USD
|
64.671%
|
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
26.25%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
92.277%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
95.336%
|
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
98.102%
|
|
Jaguar Health, Inc.
|
-107.42 USD
|
99.451%
|
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
98.768%
|
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
57.554%
|
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-11.321%
|
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
99.095%
|
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
76.68%
|
|
Verastem, Inc.
|
-3.96 USD
|
85.101%
|
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
78.545%
|
|
Histogen Inc.
|
-3.46 USD
|
82.948%
|
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
85.063%
|
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-59.459%
|
|
Surrozen, Inc.
|
-21.33 USD
|
97.234%
|
|
Organovo Holdings, Inc.
|
-1.60 USD
|
63.125%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
77.82%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
4.839%
|
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
62.42%
|
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
95.211%
|
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
76.113%
|
|
Kronos Bio, Inc.
|
-1.95 USD
|
69.744%
|
|
Turnstone Biologics Corp.
|
-4.77 USD
|
87.631%
|
|
Synaptogenix, Inc.
|
-29.56 USD
|
98.004%
|
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-268.75%
|
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-195.0%
|
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-9.259%
|
|
Exelixis, Inc.
|
0.65 USD
|
190.769%
|
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
77.736%
|
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
86.742%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
90.453%
|
|
ESSA Pharma Inc.
|
-0.60 USD
|
1.667%
|
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
88.931%
|
|
Avid Bioservices, Inc.
|
-2.23 USD
|
73.543%
|
|
Insmed Incorporated
|
-5.34 USD
|
88.951%
|
|
MediWound Ltd.
|
-0.75 USD
|
21.333%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-15.686%
|
|
Alector, Inc.
|
-1.56 USD
|
62.179%
|
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
33.708%
|
|
Zai Lab Limited
|
-3.46 USD
|
82.948%
|
|
AlloVir, Inc.
|
-1.83 USD
|
67.76%
|
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
84.595%
|
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
69.898%
|
|
Aura Biosciences, Inc.
|
-1.93 USD
|
69.43%
|
|
Immunic, Inc.
|
-2.11 USD
|
72.038%
|
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
87.229%
|
|
Veracyte, Inc.
|
-1.02 USD
|
42.157%
|
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
41.584%
|
|
FibroGen, Inc.
|
-2.92 USD
|
79.795%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
98.052%
|
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
188.06%
|
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
89.154%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
96.748%
|
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
97.794%
|
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
180.822%
|
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-1440.47%
|
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
82.849%
|
|
XBiotech Inc.
|
-0.81 USD
|
27.16%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
90.453%
|
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
88.654%
|
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
55.97%
|
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
53.175%
|
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
74.786%
|
|
Agenus Inc.
|
-13.75 USD
|
95.709%
|
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-20.408%
|
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
41.0%
|
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
92.848%
|
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
67.582%
|
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
50.0%
|
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
65.497%
|
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
77.903%
|
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
84.309%
|
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
71.359%
|
|
Lantern Pharma Inc.
|
-1.47 USD
|
59.864%
|
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-36775.0%
|
|
Ainos, Inc.
|
-3.36 USD
|
82.44%
|
|
Pluri Inc.
|
-3.99 USD
|
85.213%
|
|
Prothena Corporation plc
|
-2.76 USD
|
78.623%
|
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-3.509%
|
|
Rallybio Corporation
|
-1.84 USD
|
67.935%
|
|
Kodiak Sciences Inc.
|
-4.97 USD
|
88.129%
|
|
Cue Biopharma, Inc.
|
-1.11 USD
|
46.847%
|
|
MeiraGTx Holdings plc
|
-1.49 USD
|
60.403%
|
|
Annexon, Inc.
|
-1.77 USD
|
66.667%
|
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
95.59%
|
|
Moderna, Inc.
|
-12.34 USD
|
95.219%
|
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
68.28%
|
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
88.762%
|
|
Blueprint Medicines Corporation
|
-8.37 USD
|
92.951%
|
|
Immix Biopharma, Inc.
|
-0.89 USD
|
33.708%
|
|
CalciMedica, Inc.
|
-7.65 USD
|
92.288%
|
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
77.567%
|
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
70.352%
|
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-9.259%
|
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
59.589%
|
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
91.523%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
91.873%
|
|
Nutriband Inc.
|
-0.69 USD
|
14.493%
|
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
83.473%
|
|
Vor Biopharma Inc.
|
-1.75 USD
|
66.286%
|
|
Roivant Sciences Ltd.
|
5.55 USD
|
110.631%
|
|
Alkermes plc
|
2.14 USD
|
127.57%
|
|
ProKidney Corp.
|
-0.57 USD
|
-3.509%
|
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
58.451%
|
|
Arcellx, Inc.
|
-1.47 USD
|
59.864%
|
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
85.063%
|
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
45.37%
|
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
20.27%
|
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-136.0%
|
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
29.762%
|
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
79.443%
|
|
MediciNova, Inc.
|
-0.17 USD
|
-247.059%
|
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
96.843%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
10.606%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
94.227%
|
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
88.805%
|
|
Biomea Fusion, Inc.
|
-3.44 USD
|
82.849%
|
|
RenovoRx, Inc.
|
-0.99 USD
|
40.404%
|
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
84.011%
|
|
Geron Corporation
|
-0.32 USD
|
-84.375%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
85.176%
|
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
77.132%
|
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
85.063%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
395.0%
|
|
Royalty Pharma plc
|
3.41 USD
|
117.302%
|
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
82.121%
|
|
Imunon, Inc.
|
-2.16 USD
|
72.685%
|
|
BioAtla, Inc.
|
-2.58 USD
|
77.132%
|
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
71.77%
|
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
29.762%
|
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
60.135%
|
|
Structure Therapeutics Inc.
|
-2.44 USD
|
75.82%
|
|
89bio, Inc.
|
-2.00 USD
|
70.5%
|
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
57.857%
|
|
aTyr Pharma, Inc.
|
-0.94 USD
|
37.234%
|
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
83.239%
|
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
88.889%
|
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
76.772%
|
|
Akari Therapeutics, Plc
|
-2.04 USD
|
71.078%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-147400.0%
|
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
127.7%
|
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
26.25%
|
|
Liquidia Corporation
|
-1.21 USD
|
51.24%
|
|
Entera Bio Ltd.
|
-0.31 USD
|
-90.323%
|
|
GH Research PLC
|
-0.68 USD
|
13.235%
|
|
Vericel Corporation
|
-0.07 USD
|
-781.913%
|
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-34.091%
|
|
Xencor, Inc.
|
-2.08 USD
|
71.635%
|
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
37.895%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
95.336%
|
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
28.916%
|
|
Vaxcyte, Inc.
|
-4.14 USD
|
85.749%
|
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
78.388%
|
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
1450.114%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
41.584%
|
|
Portage Biotech Inc.
|
-3.70 USD
|
84.054%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
10.606%
|
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
72.43%
|
|
OncoCyte Corporation
|
-3.75 USD
|
84.267%
|
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
76.016%
|
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
93.042%
|
|
Purple Biotech Ltd.
|
-0.09 USD
|
-557.016%
|
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
69.11%
|
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
41.584%
|
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
81.563%
|
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
4.839%
|
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
96.085%
|
|
United Therapeutics Corporation
|
21.04 USD
|
102.804%
|
|
HilleVax, Inc.
|
-3.04 USD
|
80.592%
|
|
Silo Pharma, Inc.
|
-1.20 USD
|
50.833%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-34.091%
|
|
Pharming Group N.V.
|
-0.16 USD
|
-268.75%
|
|
Tharimmune, Inc.
|
-107.08 USD
|
99.449%
|
|
Genprex, Inc.
|
-22.58 USD
|
97.387%
|
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-17252.941%
|
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
60.403%
|
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
68.108%
|
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-17778.788%
|
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-110.714%
|
|
OKYO Pharma Limited
|
-0.00 USD
|
-98233.333%
|
|
Savara Inc.
|
-0.33 USD
|
-78.788%
|
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
99.36%
|
|
Curis, Inc.
|
-8.96 USD
|
93.415%
|
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
59.589%
|
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
60.667%
|
|
BeiGene, Ltd.
|
-8.45 USD
|
93.018%
|
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
57.554%
|
|
Erasca, Inc.
|
-0.83 USD
|
28.916%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
48.696%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
48.696%
|
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
68.783%
|
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
38.542%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
78.467%
|
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
79.795%
|
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
75.62%
|
|
Adicet Bio, Inc.
|
-3.31 USD
|
82.175%
|
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-15.686%
|
|
Aditxt, Inc.
|
-4326.64 USD
|
99.986%
|
|
Adagene Inc.
|
-0.44 USD
|
-34.091%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-180.952%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
13.235%
|
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
48.696%
|
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
119.156%
|
|
Compugen Ltd.
|
-0.21 USD
|
-180.952%
|
|
Generation Bio Co.
|
-1.96 USD
|
69.898%
|
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
75.62%
|
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
68.617%
|
|
Invivyd, Inc.
|
-1.81 USD
|
67.403%
|
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
78.853%
|
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
93.88%
|
|
Spero Therapeutics, Inc.
|
0.43 USD
|
237.209%
|
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
83.095%
|
|
2seventy bio, Inc.
|
-4.42 USD
|
86.652%
|
|
Instil Bio, Inc.
|
-24.00 USD
|
97.542%
|
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
28.916%
|
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-47.5%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
94.227%
|
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-168.182%
|
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
82.012%
|
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
84.225%
|
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
87.146%
|
|
Evaxion Biotech A/S
|
-8.11 USD
|
92.725%
|
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
45.872%
|
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
81.09%
|
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
63.58%
|
|
Cingulate Inc.
|
-311.99 USD
|
99.811%
|
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
98.037%
|
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
78.148%
|
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
45.37%
|
|
Clearmind Medicine Inc.
|
-59.18 USD
|
99.003%
|
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
67.76%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-51.282%
|
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
35.165%
|
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
97.049%
|
|
ImmunityBio, Inc.
|
-1.15 USD
|
48.696%
|
|
Korro Bio, Inc.
|
-53.08 USD
|
98.888%
|
|
Kineta, Inc.
|
-1.28 USD
|
53.906%
|
|
BioVie Inc.
|
-7.30 USD
|
91.918%
|
|
Codexis, Inc.
|
-1.12 USD
|
47.321%
|
|
Celularity Inc.
|
-11.02 USD
|
94.646%
|
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
82.749%
|
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
84.011%
|
|
Virax Biolabs Group Limited
|
-3.36 USD
|
82.44%
|
|
Cibus, Inc.
|
-25.95 USD
|
97.726%
|
|
IN8bio, Inc.
|
-1.00 USD
|
41.0%
|
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
94.923%
|
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
99.481%
|
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
76.953%
|
|
Eyenovia, Inc.
|
-0.66 USD
|
10.606%
|
|
Puma Biotechnology, Inc.
|
0.46 USD
|
228.261%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-552.655%
|
|
Elevation Oncology, Inc.
|
-1.34 USD
|
55.97%
|
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
78.777%
|
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
36.559%
|
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
90.752%
|
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
62.658%
|
|
Moolec Science SA
|
-1.50 USD
|
60.667%
|
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
45.37%
|
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
62.42%
|
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
63.804%
|
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-78.788%
|
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
14.493%
|
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
95.021%
|
|
Humacyte, Inc.
|
-1.07 USD
|
44.86%
|
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
59.028%
|
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
99.198%
|
|
Genelux Corporation
|
-1.16 USD
|
49.138%
|
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-103.448%
|
|
Notable Labs, Ltd.
|
-5.03 USD
|
88.27%
|
|
Immunovant, Inc.
|
-1.88 USD
|
68.617%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
13.235%
|
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
1.667%
|
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
73.778%
|
|
Acasti Pharma Inc.
|
-1.35 USD
|
56.296%
|
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
9.231%
|
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
75.0%
|
|
PepGen Inc.
|
-3.30 USD
|
82.121%
|
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
58.741%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-103.448%
|
|
Immuneering Corporation
|
-1.88 USD
|
68.617%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
77.82%
|
|
Belite Bio, Inc
|
-1.19 USD
|
50.42%
|
|
XOMA Corporation
|
-4.04 USD
|
85.396%
|
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
-3.509%
|
|
Bionomics Limited
|
-1.02 USD
|
42.157%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-40.476%
|
|
uniQure N.V.
|
-6.47 USD
|
90.881%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-180.952%
|
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
56.934%
|
|
Forte Biosciences, Inc.
|
-24.92 USD
|
97.632%
|
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-84.375%
|
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
62.179%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-552.655%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
98.052%
|
|
Altimmune, Inc.
|
-1.66 USD
|
64.458%
|
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
96.144%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-40.476%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
54.615%
|
|
Benitec Biopharma Inc.
|
-5.36 USD
|
88.993%
|
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
98.799%
|
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
89.033%
|
|
Zura Bio Limited
|
-2.09 USD
|
71.77%
|
|
PolyPid Ltd.
|
-16.99 USD
|
96.527%
|
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
89.033%
|
|
argenx SE
|
-5.16 USD
|
88.566%
|
|
Immunome, Inc.
|
-5.38 USD
|
89.033%
|
|
Verona Pharma plc
|
-0.54 USD
|
-9.259%
|
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
86.918%
|
|
Shattuck Labs, Inc.
|
-2.05 USD
|
71.22%
|
|
CervoMed Inc.
|
-0.82 USD
|
28.049%
|
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
86.085%
|
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
93.018%
|
|
Moolec Science SA
|
-1.50 USD
|
60.667%
|
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
92.707%
|
|
Design Therapeutics, Inc.
|
-1.19 USD
|
50.42%
|
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
85.176%
|
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
92.367%
|
|
Achilles Therapeutics plc
|
-1.74 USD
|
66.092%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-51.282%
|
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
96.23%
|
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
70.202%
|
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
55.639%
|
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
19.178%
|
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
93.348%
|
|
Beam Therapeutics Inc.
|
-1.72 USD
|
65.698%
|
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
85.25%
|
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
75.82%
|
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
70.647%
|
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
97.567%
|
|
NeurAxis, Inc.
|
-4.03 USD
|
85.36%
|
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
68.783%
|
|
Lumos Pharma, Inc.
|
-4.18 USD
|
85.885%
|
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
186.765%
|
|
Palisade Bio, Inc.
|
-27.01 USD
|
97.816%
|
|
Nutriband Inc.
|
-0.69 USD
|
14.493%
|
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
38.542%
|
|
Neurogene Inc.
|
-2.83 USD
|
79.152%
|
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
81.734%
|
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
75.21%
|
|
Athira Pharma, Inc.
|
-3.10 USD
|
80.968%
|
|
HCW Biologics Inc.
|
-0.70 USD
|
15.714%
|
|
XOMA Corporation
|
-4.04 USD
|
85.396%
|
|
Nektar Therapeutics
|
-1.45 USD
|
59.31%
|
|
Arvinas, Inc.
|
-6.62 USD
|
91.088%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-147400.0%
|
|
Merus N.V.
|
-3.00 USD
|
80.333%
|
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
67.222%
|
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
29.762%
|
|
Rezolute, Inc.
|
-1.33 USD
|
55.639%
|
|
Clene Inc.
|
-9.43 USD
|
93.743%
|
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
67.935%
|
|
BeyondSpring Inc.
|
-0.54 USD
|
-9.259%
|
|
Synlogic, Inc.
|
-8.81 USD
|
93.303%
|
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-5628.155%
|
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
98.741%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
43.81%
|
|
Krystal Biotech, Inc.
|
0.40 USD
|
247.5%
|
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
52.8%
|
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
88.544%
|
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
23.377%
|
|
MannKind Corporation
|
-0.04 USD
|
-1219.911%
|
|
Ikena Oncology, Inc.
|
-1.63 USD
|
63.804%
|
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
93.437%
|
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
58.156%
|
|
Gossamer Bio, Inc.
|
-1.18 USD
|
50.0%
|
|
CohBar, Inc.
|
-4.13 USD
|
85.714%
|
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
31.395%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
85.176%
|
|
Legend Biotech Corporation
|
-2.94 USD
|
79.932%
|
|
Mural Oncology plc
|
-12.43 USD
|
95.253%
|
|
Disc Medicine, Inc.
|
-3.43 USD
|
82.799%
|
|
Champions Oncology, Inc.
|
-0.54 USD
|
-9.259%
|
|
REGENXBIO Inc.
|
-6.02 USD
|
90.199%
|
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
87.42%
|
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
1.667%
|
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
81.029%
|
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
62.42%
|
|
Vaxart, Inc.
|
-0.57 USD
|
-3.509%
|
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
67.222%
|
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
7.813%
|
|
Cellectis S.A.
|
-1.77 USD
|
66.667%
|
|
Longeveron Inc.
|
-10.22 USD
|
94.227%
|
|
Repare Therapeutics Inc.
|
-2.23 USD
|
73.543%
|
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
89.828%
|
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
56.934%
|
|
Revolution Medicines, Inc.
|
-3.86 USD
|
84.715%
|
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-702.721%
|
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
24.359%
|
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
72.811%
|
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
78.467%
|
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-84.375%
|
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
104.199%
|
|
Denali Therapeutics Inc.
|
-1.06 USD
|
44.34%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-11.321%
|
|
Veru Inc.
|
-1.10 USD
|
46.364%
|
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-5.357%
|
|
Cingulate Inc.
|
-311.99 USD
|
99.811%
|
|
Passage Bio, Inc.
|
-1.86 USD
|
68.28%
|
|
Context Therapeutics Inc.
|
-1.50 USD
|
60.667%
|
|
Exicure, Inc.
|
-2.11 USD
|
72.038%
|
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
75.105%
|
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
39.175%
|
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
96.45%
|
|
Nuvalent, Inc.
|
-2.17 USD
|
72.811%
|
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
75.72%
|
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
77.22%
|
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
53.906%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-15.686%
|
|
Anew Medical, Inc.
|
0.14 USD
|
521.429%
|
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
1.667%
|
|
Lipocine Inc.
|
-3.14 USD
|
81.21%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
76.305%
|
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-15.686%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
92.277%
|
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
36.559%
|
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
71.635%
|
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
93.481%
|
|
Ocugen, Inc.
|
-0.26 USD
|
-126.923%
|
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
75.82%
|
|
Q32 Bio Inc.
|
-35.16 USD
|
98.322%
|
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-47.5%
|
|
Alumis Inc. Common Stock
|
-2.99 USD
|
80.268%
|
|
Equillium, Inc.
|
-0.38 USD
|
-55.263%
|
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-589900.0%
|
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
25.316%
|
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
99.765%
|
|
Dominari Holdings Inc.
|
-4.38 USD
|
86.53%
|
|
Edesa Biotech, Inc.
|
-2.93 USD
|
79.863%
|
|
vTv Therapeutics Inc.
|
-9.71 USD
|
93.924%
|
|
Bio-Techne Corporation
|
1.07 USD
|
155.14%
|
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
90.679%
|
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
127.189%
|
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
70.792%
|
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
54.962%
|
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
81.27%
|
|
Nkarta, Inc.
|
-2.40 USD
|
75.417%
|
|
BioCardia, Inc.
|
-8.19 USD
|
92.796%
|
|
Iterum Therapeutics plc
|
-2.96 USD
|
80.068%
|
